GlassScriptPhysician profile
Deborah W Bernstein
NPI 1326005919
$2,323.04
in general payments reported to CMS, 2019-2025
19 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $147 · 2021: $201 · 2022: $366 · 2023: $212 · 2024: $515 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,162.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $809.20 | 2019-2025 | Clareon, Rocklatan, Eysuvis |
| Novartis Pharmaceuticals Corporation | $226.66 | 2019-2023 | |
| Glaukos Corporation | $209.76 | 2024-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr, Istent Infinite |
| Abbvie INC. | $180.22 | 2019-2025 | Alphagan P, Lumigan, Vuity |
| Bausch & Lomb Americas INC. | $162.77 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Allergan, INC. | $96.04 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $94.74 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $87.60 | 2021-2025 | Eylea Hd |
| Harrow Eye, LLC | $86.99 | 2024-2025 | Vevye |
| Thea Pharma INC. | $69.83 | 2023-2024 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $55.82 | 2019-2023 | Cequa |
| Rxsight INC | $55.37 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Tarsus Pharmaceuticals, INC. | $48.28 | 2024-2025 | Xdemvy |
| Rayner Intraocular Lenses Limited | $44.15 | 2022-2023 | Rayone Spheric, Omidria, Rayone Emv |
| Biotissue Holdings INC. | $33.83 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $26.96 | 2023 | Vabysmo |
| Shire North American Group INC | $13.63 | 2019 | |
| Aerie Pharmaceuticals, INC. | $13.48 | 2019 | |
| New World Medical,INC. | $7.71 | 2025 | Ahmed Glaucoma Valve, Clearpath, Kahook Dual Blade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.